Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...

IL-23, and IL-17 were associated with a lower rate of serious infections among older adults with psoriatic disease, a ...

Methotrexate (MTX) is a drug that has been used to treat psoriatic arthritis (PsA) for more than 40 years. Alone or in combination with other therapies, MTX is considered a first-line treatment ...

Treatment with deucravacitinib in patients with active PsA showed higher response rates and improvement in quality of life ...

Tremfya is also approved to treat patients with plaque psoriasis, active psoriatic arthritis and ulcerative colitis and is ...

psoriatic arthritis, Crohn’s disease and ulcerative colitis, jumped from the 10th to fifth spot. The three that fell off the list from 2024 are Pfizer’s COVID-19 vaccine and two cancer medications, ...

Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...

Guselkumab is the first and only interleukin-23 inhibitor that offers both subcutaneous and intravenous induction options for ...